Single-Dose Oxford COVID Vax Data Bolsters Prime-Boost Strategy

(MedPage Today) -- One standard dose of the AstraZeneca/Oxford COVID-19 vaccine was highly effective against symptomatic disease up to 3 months later, lending support to a prime-boost vaccination strategy, additional analyses of phase III vaccine...